Related Experiment Video
Updated: May 23, 2026
08:19
Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
Published on: November 17, 2015
Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Shengpeng Wang1, Tongkai Chen, Ruie Chen
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Av. Padre Tomas Pereira S.J., Taipa, Macau, 999078, China.
International Journal of Pharmaceutics
|April 3, 2012
Summary
Solid lipid nanoparticles loaded with emodin (E-SLNs) were prepared using high-pressure homogenization. E-SLNs demonstrated enhanced antitumor activity against breast cancer cells by inducing cell cycle arrest and apoptosis, suggesting a promising cancer therapy approach.
Area of Science:
- Nanotechnology
- Pharmacology
- Oncology
Background:
- Emodin (EMO) is a natural compound with potential antitumor properties but suffers from poor aqueous solubility.
- Developing effective drug delivery systems is crucial for enhancing the therapeutic efficacy of poorly soluble drugs like emodin.
Purpose of the Study:
- To prepare and characterize emodin-loaded solid lipid nanoparticles (E-SLNs).
- To evaluate the in vitro antitumor activity and underlying mechanisms of E-SLNs against human breast cancer cells.
Main Methods:
- E-SLNs were prepared using high-pressure homogenization with Poloxamer 188 and Tween 80 as surfactants.
- Physicochemical properties, including particle size, zeta potential, entrapment efficiency, stability, and in vitro release, were assessed.
- In vitro cytotoxicity, cell cycle arrest, and apoptosis were evaluated using MTT assay, flow cytometry, Hoechst 33342 staining, and Annexin V-FITC/PI double staining.
Main Results:
- E-SLNs exhibited a stable particle size of 28.6 ± 3.1 nm with high drug entrapment efficiency and good physical stability over 4 months.
- E-SLNs demonstrated sustained drug release over 72 hours, indicating potential for oral drug delivery.
- E-SLNs significantly enhanced cytotoxicity against MCF-7 and MDA-MB-231 breast cancer cells compared to emodin solution, without toxicity to normal mammary epithelial cells.
- E-SLNs induced greater cell cycle arrest and apoptosis in MCF-7 cells, suggesting these as mechanisms for enhanced cytotoxicity.
Conclusions:
- High-pressure homogenization is an effective method for preparing high-quality E-SLNs with improved aqueous solubility.
- Emodin-loaded solid lipid nanoparticles represent a promising approach for enhancing the therapeutic potential of emodin in cancer therapy.
